• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AV-TEMECULA-CT ABSORB GT1 BIORESORBABLE VASCULAR SCAFFOLD SYSTEM; BIORESORBABLE DRUG ELUTING SCAFFOLD

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AV-TEMECULA-CT ABSORB GT1 BIORESORBABLE VASCULAR SCAFFOLD SYSTEM; BIORESORBABLE DRUG ELUTING SCAFFOLD Back to Search Results
Catalog Number 1235350-18
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Myocardial Infarction (1969); Thrombosis (2100)
Event Date 11/01/2016
Event Type  Injury  
Manufacturer Narrative
(b)(4).During processing of this complaint, attempts were made to obtain complete event, patient and device information.The scaffold remains in the patient.Investigation is not yet complete.A follow up report will be submitted with all additional relevant information.
 
Event Description
It was reported that the initial procedure on (b)(6) 2016 was to treat a lesion located in the mid-proximal left anterior descending coronary artery.Pre-dilatation was performed, reducing the stenosis to less than 40%, prior to implanting the absorb gt1 3.5 x 18 mm scaffold.It was confirmed that the patient had been compliant in following the dual anti platelet drug therapy after the procedure.On (b)(6) 2016, the patient returned with an st segment elevation myocardial infarction (stemi) and scaffold thrombosis was discovered.After aspiration of the thrombosis, balloon angioplasty was performed and a xience alpine 4.0 x 28 mm stent was implanted.Post-dilatation was performed with a non-compliant non-abbott 4.0 x 20 mm balloon and the final patient outcome was good.No additional information was provided.
 
Manufacturer Narrative
(b)(4).The device was not returned for evaluation.A cine was received and reviewed by an abbott vascular physician.The reviewer concluded that the sub-acute thrombosis of the absorb scaffold in the proximal lad was most likely due to untreated (unrecognized) proximal edge dissection that seems to have resulted in a compressive intra-mural hematoma or intra-scaffold thrombosis based on review of all angiograms and the intravascular ultrasound at the time of the occlusion.Thus, the event seems to have been the result of a procedural mechanical complication.The reported patient effects of dissection, myocardial infarction and thrombosis, as listed in the absorb gt1 instructions for use are known adverse events associated with the use of a coronary scaffold in native coronary arteries.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Based on the case information and related record review, a conclusive cause for the reported patient effects, and the relationship to the product, if any, cannot be determined.Based on the information reviewed, there is no indication of a product quality issue with respect to manufacture, design or labeling.
 
Event Description
A review of the cine by an abbott vascular physician noted a dissection at the proximal edge of the absorb gt1 scaffold.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ABSORB GT1 BIORESORBABLE VASCULAR SCAFFOLD SYSTEM
Type of Device
BIORESORBABLE DRUG ELUTING SCAFFOLD
Manufacturer (Section D)
AV-TEMECULA-CT
abbott vascular
26531 ynez road
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, TEMECULA, CA USA REG# 2024168
abbott vascular
26531 ynez road
temecula CA 92591 4628
Manufacturer Contact
connie speck
abbott vascular
26531 ynez road
temecula, CA 92591-4628
9519143996
MDR Report Key6124681
MDR Text Key60789753
Report Number2024168-2016-08299
Device Sequence Number1
Product Code PNY
UDI-Device Identifier08717648213120
UDI-Public(01)08717648213120(17)170718(10)6071961
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P150023
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Health Professional
Remedial Action Other
Type of Report Initial,Followup
Report Date 01/13/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date07/18/2017
Device Catalogue Number1235350-18
Device Lot Number6071961
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 11/01/2016
Initial Date FDA Received11/23/2016
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received01/13/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured07/01/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention; Disability;
Patient Age67 YR
Patient Weight118
-
-